Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| APTARGROUP, INC.ATR · Entity 165 | Director | July 16, 2026 | July 17, 2026 |
| Enovis CORPENOV · Entity 4797 | Director · CEO | March 07, 2025 | March 12, 2025 |
| Solstice Advanced Materials Inc.SOLS · Entity 3540 | Director | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
APTARGROUP, INC.
Report date July 16, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,306.85 |
Reported balance
After 2026-07-16 transaction · row 1
1 source rowRow 1 · 2026-07-16 · Grant · Acquired 151 · Balance 9,306.85 |
Enovis CORP
Report date March 07, 2025 · Filed March 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.001SEC Table I · non-derivative | Direct | 373,514 |
Reported balance
After 2025-03-07 transaction · row 1
1 source rowRow 1 · 2025-03-07 · Grant · Acquired 94,135 · Balance 373,514 F1: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.
Solstice Advanced Materials Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,893 |
Reported balance
After 2026-09-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-10 · Grant · Acquired 2 · Balance 1,893 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same time as the underlying RSUs. F3: The RSUs will vest on the earliest of the first anniversary of the grant date and the next annual meeting of shareowners of the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 1,822 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,822 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number.
F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same time as the underlying RSUs.
F3: The RSUs will vest on the earliest of the first anniversary of the grant date and the next annual meeting of shareowners of the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2021 Filed Sep 15, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 59,563 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0001209191-21-056221 · doc4.xml · derivative · entry 3 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock, par value $.001 · 59,563 shares Expires 2023-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 59,563 | $46.66 | $2,779,030.89 |
DisclosureSEC source: 0001209191-21-056221 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.08 to $47.02, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 59,563 | $23.74 | $1,414,025.62 |
DisclosureSEC source: 0001209191-21-056221 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,271 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,446 | $0.00 Strike: $39.54 | $0.00 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · derivative · entry 9 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,154 Underlying: Common stock, par value $.001 · 1,446 shares Expires 2022-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 7/24/2015. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · derivative · entry 8 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,563 Underlying: Common stock, par value $.001 · 150,000 shares Expires 2023-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,446 | $49.51 | $71,588.57 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 7 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F6 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.53, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (6) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 4,294 | $49.50 | $212,531.53 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 6 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,154 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F5 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.46 to $49.56, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 5,290 | $49.49 | $261,786.23 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 5 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,448 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.45 to $49.56, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 69,710 | $48.97 | $3,413,838.12 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 4 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,738 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.45 to $49.44, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 70,706 | $48.98 | $3,463,179.88 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 3 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,448 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.46 to $49.46, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 1,446 | $39.54 | $57,174.84 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,154 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2021 Filed Aug 18, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 150,000 | $23.74 | $3,561,000.00 |
DisclosureSEC source: 0001209191-21-052303 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0001209191-21-047613 · doc4.xml · derivative · entry 4 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,563 Underlying: Common stock, par value $.001 · 75,000 shares Expires 2023-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 7,049 | $43.15 | $304,136.15 |
DisclosureSEC source: 0001209191-21-047613 · doc4.xml · nonDerivative · entry 3 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.03 to $43.36, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 67,951 | $42.63 | $2,896,954.98 |
DisclosureSEC source: 0001209191-21-047613 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,757 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $43.02, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 22:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 75,000 | $23.74 | $1,780,500.00 |
DisclosureSEC source: 0001209191-21-047613 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0001209191-21-042837 · doc4.xml · derivative · entry 3 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,563 Underlying: Common stock, par value $.001 · 75,000 shares Expires 2023-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 75,000 | $44.41 | $3,330,450.00 |
DisclosureSEC source: 0001209191-21-042837 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.81 to $44.69, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 23:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 75,000 | $23.74 | $1,780,500.00 |
DisclosureSEC source: 0001209191-21-042837 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $23.74 | $0.00 |
DisclosureSEC source: 0001209191-21-033314 · doc4.xml · derivative · entry 3 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,563 Underlying: Common stock, par value $.001 · 200,000 shares Expires 2023-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 1/4/2016. Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 200,000 | $43.14 | $8,628,400.00 |
DisclosureSEC source: 0001209191-21-033314 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.89 to $43.18, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| May 14, 2021 Filed May 18, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | Exercise / conversionCommon stock, par value $.001 | 200,000 | $23.74 | $4,748,000.00 |
DisclosureSEC source: 0001209191-21-033314 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2021 Filed Mar 10, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 72,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-019312 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,708 F1 · kind: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 25, 2021 Filed Feb 27, 2021 02:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 6,057 | $46.01 | $278,682.57 |
DisclosureSEC source: 0001209191-21-015058 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,699 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of certain restricted stock units. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:58 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 95,502 | $0.00 Strike: $44.91 | $0.00 |
DisclosureSEC source: 0001209191-21-014085 · doc4.xml · derivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,502 Underlying: Common stock, par value $.001 · 95,502 shares Expires 2028-02-21 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 01:58 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon stock, par value $.001 | 38,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-014085 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,756 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 05, 2021 Filed Jan 8, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 1,668 | $38.51 | $64,229.68 |
DisclosureSEC source: 0001209191-21-002616 · doc4.xml · nonDerivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,967 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020. These shares were sold to meet tax obligations relating to the vesting and delivery of the third tranche of performance-based restricted stock units granted to Mr. Trerotola in January 2016. F3 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.44-$38.61, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 05, 2021 Filed Jan 8, 2021 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 20,371 | $38.09 | $775,951.76 |
DisclosureSEC source: 0001209191-21-002616 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,635 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 11, 2020. These shares were sold to meet tax obligations relating to the vesting and delivery of the third tranche of performance-based restricted stock units granted to Mr. Trerotola in January 2016. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.44-$38.43, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 27, 2020 Filed Jul 28, 2020 00:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon stock, par value $.001 | 19,481 | $30.83 | $600,599.23 |
DisclosureSEC source: 0001209191-20-043791 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,006 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of the third tranche of performance-based restricted stock units granted to Mr. Trerotola upon his hire. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 23:28 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 119,416 | $0.00 Strike: $37.67 | $0.00 |
DisclosureSEC source: 0001209191-20-013194 · doc4.xml · derivative · entry 2 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,416 Underlying: Common Stock, par value $.001 · 119,416 shares Expires 2027-02-23 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 23:28 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 39,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013194 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,487 F1 · shares: This award represents restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:51 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 22,317 | $36.84 | $822,158.28 |
DisclosureSEC source: 0001209191-20-002548 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,287 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2019. These shares were sold to meet tax obligations relating to the vesting and delivery of the second tranche of performance-based restricted stock units granted to Mr. Trerotola in January 2016. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.41 to $37.07, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| July 25, 2019 Filed Jul 29, 2019 21:11 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 18,589 | $28.51 | $529,972.39 |
DisclosureSEC source: 0001209191-19-043527 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,604 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person to meet tax obligations relating to the vesting and delivery of the second tranche of performance-based restricted stock units granted to Mr. Trerotola upon his hire. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.21 to $29.00, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 22:23 UTC | Enovis CORP CFX · Entity 4797 | GrantEmployee Stock Option (right to buy) · Derivative | 310,364 | $0.00 Strike: $26.88 | $0.00 |
DisclosureSEC source: 0001209191-19-014149 · doc4.xml · derivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,364 Underlying: Common Stock, par value $.001 · 310,364 shares Expires 2026-02-24 F1 · derivative.exercise_date: The option vests in three equal annual installments on the first, second, and third anniversaries of the grant date. Read SEC document |
| January 07, 2019 Filed Jan 10, 2019 00:25 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 22,553 | $21.36 | $481,732.08 |
DisclosureSEC source: 0001209191-19-003158 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,193 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 26, 2018. These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted to Mr. Trerotola in January 2016. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.06 to $21.53, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 21:00 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 20,488 | $33.32 | $682,701.14 |
DisclosureSEC source: 0001209191-18-046058 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,746 F1 · kind: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted to Mr. Trerotola upon his hire. F1 · shares: These shares were sold to meet tax obligations relating to the vesting and delivery of the first tranche of performance-based restricted stock units granted to Mr. Trerotola upon his hire. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 20:22 UTC | Enovis CORP CFX · Entity 4797 | GrantCommon Stock, par value $.001 | 242,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-045675 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,234 F1 · kind: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. F1 · shares: Reflects the certification of the performance criteria for previously awarded performance-based restricted stock units ("PRSUs"), which PRSUs vest over time. For more details on the PRSUs, please refer to the "Outstanding Equity Awards" table on page 39 of the Company's Proxy Statement as filed with the SEC on April 5, 2018. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 21:10 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 16,186 | $39.76 | $643,474.43 |
DisclosureSEC source: 0001209191-18-000798 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,670 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2017. These shares were sold to meet tax obligations relating to the vesting and delivery of the third and final tranche of restricted stock units granted to Mr. Trerotola upon his hire. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.72 to $39.87, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 21:35 UTC | Enovis CORP CFX · Entity 4797 | SaleCommon Stock, par value $.001 | 16,929 | $36.75 | $622,140.75 |
DisclosureSEC source: 0001209191-17-000950 · doc4.xml · nonDerivative · entry 1 Trerotola Matthew L. · CIK 0001625057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,856 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2016. These shares were sold to meet tax obligations relating to the vesting and delivery of the second tranche of restricted stock units granted to Mr. Trerotola upon his hire. F2 · price: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $37.08, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.